Literature DB >> 31394351

Corpus callosotomy for drug-resistant spasms associated with tuberous sclerosis complex.

Tohru Okanishi1, Ayataka Fujimoto2, Kazuo Okanari3, Shimpei Baba4, Naoki Ichikawa2, Mitsuyo Nishimura5, Hideo Enoki4.   

Abstract

BACKGROUND: Corpus callosotomy (CC) has recently been adopted for the treatment of drug-resistant epileptic spasms and tonic spasms. In the present study, we investigated CC outcomes among patients with drug-resistant epileptic spasms or tonic spasms associated with tuberous sclerosis complex (TSC).
METHODS: We retrospectively collected data from seven patients (3 women, 4 men) with diagnosed TSC and who were treated using CC at Seirei Hamamatsu General Hospital in Japan. All patients had experienced drug-resistant epileptic spasms (<3 s of muscular contraction) or tonic spasms (>3 s) prior to CC, which were confirmed via video-electroencephalogram monitoring.
RESULTS: All patients exhibited multiple bilateral cortical tubers on brain magnetic resonance imaging. The main seizure types were epileptic spasms in four, tonic spasms in one, and both seizure types in two patients. Patients underwent total CC between the ages of 25 months and 21.5 years. Additional resection or disconnection was performed in two patients. The follow-up period after CC ranged between 9 months and 3.5 years. Three patients achieved remission from spasms following CC alone. Two other patients became free from spasms several months after CC but required an additional focus disconnection or medical treatment. The remaining two patients continued to show spasms or asymmetrical tonic seizures.
CONCLUSION: Total CC resulted in freedom from drug-resistant epileptic or tonic spasms in several patients with TSC. Stepwise progression from CC to additional resection or disconnection surgery may aid in the treatment of spasms secondary to TSC.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Corpus callosotomy; Cortical tubers; Intractable epilepsy; Spasms; Tuberous sclerosis complex

Mesh:

Year:  2019        PMID: 31394351     DOI: 10.1016/j.yebeh.2019.06.007

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  4 in total

1.  Epilepsy surgery in tuberous sclerosis complex (TSC): emerging techniques and redefinition of treatment goals.

Authors:  Jeffrey M Treiber; Daniel J Curry; Howard L Weiner; Jonathan Roth
Journal:  Childs Nerv Syst       Date:  2020-06-13       Impact factor: 1.475

Review 2.  Pharmacotherapy for Seizures in Tuberous Sclerosis Complex.

Authors:  Rima Nabbout; Mathieu Kuchenbuch; Catherine Chiron; Paolo Curatolo
Journal:  CNS Drugs       Date:  2021-08-21       Impact factor: 5.749

3.  Corpus Callosotomy: Editorial.

Authors:  Ayataka Fujimoto; Tohru Okanishi
Journal:  Brain Sci       Date:  2022-07-29

Review 4.  Corpus Callosotomy for Controlling Epileptic Spasms: A Proposal for Surgical Selection.

Authors:  Tohru Okanishi; Ayataka Fujimoto
Journal:  Brain Sci       Date:  2021-12-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.